Every parent aspires to nurture life and to cradle their bundle of joy. Yet some parents meet with unforeseen hurdles on this path that test their determination and make them rethink their paths. Within this landscape, the donor egg IVF (in-vitro fertilization) emerges as the torchbearer of opportunities, presenting an avenue to parenthood. The intensified public discussion, awareness campaign, and media exposure aid in curbing the stigma surrounding infertility treatments, encouraging individuals to seek help.
Recent revisions in market analysis indicate an amplification in demand for donor egg IVF (in-vitro fertilization) are accounted for the forecast valuation of US$ 3,347.10 million in 2024. Sales of donor egg IVF (in-vitro fertilization) are proficient to attain the worth and strike US$ 7,159.50 million by 2034 as these trends gain momentum and become prevalent. This portrays a robust 7.90% CAGR between 2024 and 2034.
Attributes | Details |
---|---|
Donor Egg IVF (In-Vitro Fertilization) Market Value for 2024 | US$ 3,347.10 million |
Donor Egg IVF (In-Vitro Fertilization) Market Value for 2034 | US$ 7,159.50 million |
Donor Egg IVF (In-Vitro Fertilization) Market CAGR from 2024 to 2034 | 7.90% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As the world witnesses couples delaying their first pregnancy which leads to a prevalence of infertility issues, it is proven that treatments such as in-vitro fertilization (IVF) and more advanced processes like donor egg IVF have the potential for skyrocketing demand.
It has been verified in numerous researches that the number of women with ovaries that have untimely ceased to function has escalated over the recent past. This infers that the donor egg sustains the opportunity for them to conceive and lead a successful pregnancy. The strengthening infertility burden brings along a robust upswing in female egg donors, which is referenced as a vital stimulus to augment prospects of the donor egg IVF market.
Attributes | Details |
---|---|
Market Value for 2019 | US$ 2,172.40 million |
Market Value for 2023 | US$ 7,159.50 million |
Market CAGR from 2019 to 2023 | 7.40% |
The categorized donor egg in-vitro fertilization market analysis is included in the preceding subsection. Based on comprehensive studies, the fresh donor egg cycle sector controls the cycle type category. Likewise, fertility clinics and IVF centers segment top the end-user category.
Segment | Fertility Clinics and IVF Centers |
---|---|
Share (2024) | 64.50% |
Fertility clinics and IVF centers cater to specialization and exhaustive services customized for patients seeking donor egg IVF, alluring a continuous stream of patients. Patients look for the tailored care and attention provided by fertility clinics and IVF centers, nurturing their trust and loyalty towards them.
The success stories linked to the prominent fertility clinics and IVF centers attract patients looking for powerful solutions to their fertility roadblocks. The association of medical professionals and specialists within fertility clinics and IVF centers strengthens the patient experience and adds to the supremacy of this segment.
Segment | Fresh Donor Egg Cycle |
---|---|
Share (2024) | 70.10% |
Demand for fresh donor egg cycle segments remains sturdy despite the progression in frozen egg preservation technologies. The fresh donor egg cycle bestows a more natural process, corresponding to patient alternatives.
The strengthening versatility in scheduling and reduced waiting times captivate more patients to fresh cycles. The fresh donor egg cycle imparts immediate solutions that align with the patient's zeal for urgency and the emotional aspect of starting a family. This suggests that there is soaring traction toward the fresh donor egg cycle segment.
The donor egg IVF (In-Vitro Fertilization) market can be observed in the subsequent tables, which focus on the leading regions in North America, Europe, and Asia Pacific. A comprehensive evaluation demonstrates that Asia Pacific has enormous market opportunities for donor egg in-vitro fertilization.
Demand Analysis of Donor Egg IVF Service in North America
Countries | CAGR (2024 to 2034) |
---|---|
United States | 7.80% |
Canada | 5.80% |
The United States exhibits innovative healthcare facilities and a strong regulatory infrastructure, warranting premium donor egg in-vitro fertilization procedures. The innovative technologies integrated with reimbursement policies assist the upsurge in the demand for donor egg IVF treatments in the United States. The amplifying donor egg in-vitro fertilization service demand in the United States is prompted by delayed childbearing, escalating infertility rates, and transitioning societal ethics.
Along with the presence of pre-eminent fertility clinics obstacles like constrained public investment and diversity in state regulations influence the adoption of donor egg IVF services in Canada. The escalating demand of patients for customized fertility treatments and the advent of boutique fertility clinics usher the assortment of the donor egg IVF (In-Vitro Fertilization) market in Canada.
Opportunities for Donor Egg IVF in Europe
Countries | CAGR (2024 to 2034) |
---|---|
France | 7.50% |
Germany | 7.30% |
BENELUX | 7.20% |
United Kingdom | 7.00% |
Brazil | 6.80% |
Russia | 6.70% |
Cultural perception toward parenthood and fertility treatments carves out the prospect of donor egg IVF (In-Vitro Fertilization) market in France. The adoption of donor eggs is enhancing, with amplifying awareness and affirmation of artificial reproduction methods in France. The regulatory regime in France delivers concise guidelines for donor egg IVF methods, warranting ethical and secure medical practices.
The patient support groups and advocacy organizations catering to Germany are vital since they provide a compassionate environment for people going through donor egg IVF and infertility issues. Fertility specialists have access to opportunities for professional growth and continuous medical education, guaranteeing that clinics sustain top-notch care while staying at the pinnacle of artificial reproduction advancements.
Donor egg IVF is one of the fertility treatments backed financially by the NHS in the United Kingdom. This makes sure that all qualified patients, regardless of their financial situation, have proper access to artificial human reproduction, broadening the adoption.
Informed consent and liberty for donors and recipients are put first by the United Kingdom’s regulatory framework, which assures transparent practices all along the donor egg IVF treatment. Education and community engagement programs assist people become aware of donor egg IVF and infertility, which minimizes the stigma and boosts the confidence to seek alternative treatment and support.
Opportunities in the Asia Pacific Industry
Countries | CAGR (2024 to 2034) |
---|---|
China | 12.90% |
India | 9.60% |
Japan | 5.90% |
The demand for donor egg IVF is bolstered by cultural expectations for biological parenthood and family lineage, especially in regions where ancestral legacy is prioritized. The potential for donor egg IVF (In-Vitro Fertilization) market expansion is facilitated by government strategies like the relaxation of the one-child policy that tries to eradicate infertility issues.
Indian couples are actively on the hunt for donor egg IVF treatments, which is somewhat due to socioeconomic issues like postponed marriages and career-focused lifestyles, escalating the demand. An array of fertility clinics and establishments catering to medical tourism makes these services widely accessible in India, amplifying the donor egg IVF (In-Vitro Fertilization) market growth.
The demand for treatment for age-related infertility is thrust by Japan's senior population and declining birth rates. The cultural stigmas associated with infertility are briskly washing out, which results in escalation in the adoption of donor egg IVF treatments in Japan.
The donor egg IVF (In-Vitro Fertilization) market is shaped by various elements like technological advancements, regulations, demographic trends, and the presence of qualified medical care professionals. Key donor egg IVF service vendors are fertility clinics, hospitals, and specialized reproductive healthcare centers.
The donor egg in-vitro fertilization treatment providers with a broad network of clinics with high demand for artificial reproductive techniques provide a competitive edge. The reputation and success rates of clinics are crucial in luring patients.
The progress in technology is another catalyst of competition. Clinics investing money in advanced techniques, like embryo screening technologies and better cryopreservation methods, upskill themselves and entice a wider customer base looking for higher success rates.
Cost is another major factor in the market's competitive landscape, as affordability is crucial in the decision-making process of the patient. Clinics that provide competitive pricing or financial assistance programs like EMIs get the upper hand in clutching patients.
The donor egg IVF market is very competitive, with service providers contending to differentiate from each other with elements like global presence, innovation, regulatory infrastructure, affordability, and most importantly, adherence to ethical bylaws and patient security.
Noteworthy Observations
Company | California Cryobank |
---|---|
Headquarter | United States |
Recent Advancement |
|
Company | ConceiveAbilities |
---|---|
Headquarter | United States |
Recent Advancement |
|
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The revenue size of donor egg IVF to attain a valuation US$ 3,347.10 million in 2024.
The demand for donor egg in-vitro fertilization (IVF) has the potential to seize an estimation of US$ 7,159.50 million by 2034.
The donor egg in-vitro fertilization sales revenue indicates to a CAGR of 7.90% through 2034.
From 2019 to 2023, the donor egg IVF market exhibited a 7.40% CAGR.
The fresh donor egg cycle sector is set to achieve a global market share of 70.10% in 2024.
The fertility clinics and IVF centers segment to possess a global market share of 64.50% in 2024.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034 4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023 4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Cycle Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Cycle Type, 2019 to 2023 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Cycle Type, 2024 to 2034 5.3.1. Fresh Donor Egg Cycle 5.3.2. Frozen Donor Egg Cycle 5.4. Y-o-Y Growth Trend Analysis By Cycle Type, 2019 to 2023 5.5. Absolute $ Opportunity Analysis By Cycle Type, 2024 to 2034 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2019 to 2023 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2024 to 2034 6.3.1. Direct / Patient 6.3.2. Hospitals 6.3.3. Fertility Clinics & IVF Centres 6.4. Y-o-Y Growth Trend Analysis By End User, 2019 to 2023 6.5. Absolute $ Opportunity Analysis By End User, 2024 to 2034 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023 7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034 7.3.1. North America 7.3.2. Latin America 7.3.3. Western Europe 7.3.4. Eastern Europe 7.3.5. South Asia and Pacific 7.3.6. East Asia 7.3.7. Middle East and Africa 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 8.2.1. By Country 8.2.1.1. USA 8.2.1.2. Canada 8.2.2. By Cycle Type 8.2.3. By End User 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Cycle Type 8.3.3. By End User 8.4. Key Takeaways 9. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Cycle Type 9.2.3. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Cycle Type 9.3.3. By End User 9.4. Key Takeaways 10. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. UK 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Western Europe 10.2.2. By Cycle Type 10.2.3. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Cycle Type 10.3.3. By End User 10.4. Key Takeaways 11. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 11.2.1. By Country 11.2.1.1. Poland 11.2.1.2. Russia 11.2.1.3. Czech Republic 11.2.1.4. Romania 11.2.1.5. Rest of Eastern Europe 11.2.2. By Cycle Type 11.2.3. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Cycle Type 11.3.3. By End User 11.4. Key Takeaways 12. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Bangladesh 12.2.1.3. Australia 12.2.1.4. New Zealand 12.2.1.5. Rest of South Asia and Pacific 12.2.2. By Cycle Type 12.2.3. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Cycle Type 12.3.3. By End User 12.4. Key Takeaways 13. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Cycle Type 13.2.3. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Cycle Type 13.3.3. By End User 13.4. Key Takeaways 14. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. South Africa 14.2.1.3. Israel 14.2.1.4. Rest of MEA 14.2.2. By Cycle Type 14.2.3. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Cycle Type 14.3.3. By End User 14.4. Key Takeaways 15. Key Countries Market Analysis 15.1. USA 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2023 15.1.2.1. By Cycle Type 15.1.2.2. By End User 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2023 15.2.2.1. By Cycle Type 15.2.2.2. By End User 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2023 15.3.2.1. By Cycle Type 15.3.2.2. By End User 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2023 15.4.2.1. By Cycle Type 15.4.2.2. By End User 15.5. Germany 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2023 15.5.2.1. By Cycle Type 15.5.2.2. By End User 15.6. UK 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2023 15.6.2.1. By Cycle Type 15.6.2.2. By End User 15.7. France 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2023 15.7.2.1. By Cycle Type 15.7.2.2. By End User 15.8. Spain 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2023 15.8.2.1. By Cycle Type 15.8.2.2. By End User 15.9. Italy 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2023 15.9.2.1. By Cycle Type 15.9.2.2. By End User 15.10. Poland 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2023 15.10.2.1. By Cycle Type 15.10.2.2. By End User 15.11. Russia 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2023 15.11.2.1. By Cycle Type 15.11.2.2. By End User 15.12. Czech Republic 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2023 15.12.2.1. By Cycle Type 15.12.2.2. By End User 15.13. Romania 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2023 15.13.2.1. By Cycle Type 15.13.2.2. By End User 15.14. India 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2023 15.14.2.1. By Cycle Type 15.14.2.2. By End User 15.15. Bangladesh 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2023 15.15.2.1. By Cycle Type 15.15.2.2. By End User 15.16. Australia 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2023 15.16.2.1. By Cycle Type 15.16.2.2. By End User 15.17. New Zealand 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2023 15.17.2.1. By Cycle Type 15.17.2.2. By End User 15.18. China 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2023 15.18.2.1. By Cycle Type 15.18.2.2. By End User 15.19. Japan 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2023 15.19.2.1. By Cycle Type 15.19.2.2. By End User 15.20. South Korea 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2023 15.20.2.1. By Cycle Type 15.20.2.2. By End User 15.21. GCC Countries 15.21.1. Pricing Analysis 15.21.2. Market Share Analysis, 2023 15.21.2.1. By Cycle Type 15.21.2.2. By End User 15.22. South Africa 15.22.1. Pricing Analysis 15.22.2. Market Share Analysis, 2023 15.22.2.1. By Cycle Type 15.22.2.2. By End User 15.23. Israel 15.23.1. Pricing Analysis 15.23.2. Market Share Analysis, 2023 15.23.2.1. By Cycle Type 15.23.2.2. By End User 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Cycle Type 16.3.3. By End User 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. California Cryobank 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.2. ConceiveAbilities 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.3. Center for Human Reproduction 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.4. Growing Generations LLC 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.5. Cryos International 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.6. Fairfax EggBank 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.7. The World Egg Bank 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.8. Global Donor Egg Bank 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.9. New Life Ukraine 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.10. First Egg Bank 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 17.1.11. MyEggBank 17.1.11.1. Overview 17.1.11.2. Product Portfolio 17.1.11.3. Profitability by Market Segments 17.1.11.4. Sales Footprint 17.1.11.5. Strategy Overview 17.1.11.5.1. Marketing Strategy 17.1.12. Ovobank 17.1.12.1. Overview 17.1.12.2. Product Portfolio 17.1.12.3. Profitability by Market Segments 17.1.12.4. Sales Footprint 17.1.12.5. Strategy Overview 17.1.12.5.1. Marketing Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Healthcare
March 2023
REP-GB-12785
330 pages
Explore Healthcare Insights
View Reports